MEXICO CITY, May 26, 2021 (LifeSiteNews) — A city-wide initiative in Mexico’s bustling capital to prescribe ivermectin to COVID-19 positive patients has resulted in a 52–76 percent reduction in hospitalizations, according to research by the Mexican Digital Agency for Public Innovation (DAPI), Mexico’s Ministry of Health, and the Mexican Social Security Institute (IMSS).
After Mexico City introduced ivermectin plan, COVID hospitalizations and deaths disappeared
Ivermectin greatly reduces covid hospitalizations and deaths in Mexico City
